Infectious etiology of acute exacerbations insevere COPD patients

Journal of Infection

Volumn 67, Issue 6, 2013, Pages 516-523

  Domenech, Arnau ^a,b   Puig, Carmen ^a,b   Martí, Sara ^a,b   Santos, Salud ^a,b   Fernández, Anabel ^a   Calatayud, Laura ^a,b   Dorca, Jordi ^a,b   Ardanuy, Carmen ^a,b   Liñares, Josefina ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acute exacerbation; Chronic obstructive pulmonary disease; Haemophilus influenzae; Pseudomonas aeruginosa; Streptococcus pneumoniae

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZTREONAM; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MACROLIDE; OXYGEN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; UNINDEXED DRUG;

AGED; AIRWAY OBSTRUCTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL LOAD; BACTERIUM DETECTION; BACTERIUM ISOLATION; CANDIDA ALBICANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENTEROBACTERIACEAE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNGAL DETECTION; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MORAXELLA CATARRHALIS; NONHUMAN; OXYGEN THERAPY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ACUTE EXACERBATION; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; HAEMOPHILUS INFLUENZAE; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

AGED; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL LOAD; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; SPUTUM;

EID: 84887024436     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.09.003     Document Type: Article

References (30)

1. Buist A.S., McBurnie M.A., Vollmer W.M., Gillespie S., Burney P., Mannino D.M., et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750.
2. Miravitlles M., Ferrer M., Pont A., Zalacain R., Alvarez-Sala J.L., Masa F., et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004, 59:387-395.
3. Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008, 359:2355-2365.
4. Decramer M., Janssens W., Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012, 379:1341-1351.
5. Eller J., Ede A., Schaberg T., Niederman M.S., Mauch H., Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998, 113:1542-1548.
6. Ko F.W., Ip M., Chan P.K., Fok J.P., Chan M.C., Ngai J.C., et al. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 2007, 131:44-52.
7. Lieberman D., Lieberman D., Ben-Yaakov M., Shmarkov O., Gelfer Y., Varshavsky R., et al. Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD. Diagn Microbiol Infect Dis 2002, 44:1-6.
8. Papaetis G.S., Anastasakou E., Orphanidou D. Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence?. Eur J Intern Med 2009, 20:579-585.
9. Anzueto A., Sethi S., Martinez F.J. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007, 4:554-564.
10. Hurst J.R., Vestbo J., Anzueto A., Locantore N., Müllerova H., Tal-Singer R., et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363:1128-1138.
11. De la Campa A.G., Ferrandiz M.J., Tubau F., Pallarés R., Manresa F., Liñares J. Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis. Antimicrobial Agents Chemother 2003, 47:1419-1422.
12. Domenech A., Ardanuy C., Balsalobre L., Marti S., Calatayud L., De la Campa A.G., et al. Pneumococci can persistently colonise adult patients with chronic respiratory disease. J Clin Microbiol 2012, 50:4047-4053.
13. Bastida T., Pérez-Vázquez M., Campos J., Cortés-Lletget M.C., Román F., Tubau F., et al. Levofloxacin treatment failure in Haemophilus influenzae pneumonia. Emerg Infect Dis 2003, 9:1475-1478.
14. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 2002, 34:634-640.
15. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47:1245-1251.
16. Rosón B., Carratalà J., Verdaguer R., Dorca J., Manresa F., Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000, 31:869-874.
17. Murray P.R., Baron E.J., Jorgensen J.H. Manual of clinical microbiology 2003, ASM Press, Washington, DC. 8th ed.
18. Welti M., Jaton K., Altwegg M., Sahli R., Wenger A., Bille J. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis 2003, 45:85-95.
19. Clinical Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing 2008, Eighteenth Informational Supplement M100-S18. Wayne, PA, USA.
20. CDC PCR deduction of pneumococcal serotypes July 2012, [date last accessed 20.12.12]. http://www.cdc.gov/ncidod/biotech/strep/pcr.htm.
21. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
22. Sethi S., Evans N., Grant B.J., Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465-471.
23. Papi A., Bellettato C.M., Braccioni F., Romagnoli M., Casolari P., Caramori G., et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006, 173:1114-1121.
24. Domenech A., Ardanuy C., Calatayud L., Santos S., Tubau F., Grau I., et al. Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother 2011, 66:487-493.
25. García-Cobos S., Campos J., Román F., Carrera C., Pérez-Vázquez M., Aracil B., et al. Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method. Antimicrobial Agents Chemother 2008, 52:2407-2414.
26. Pfaller M.A., Farrell D.J., Sader H.S., Jones R.N. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. Clin Infect Dis 2012, 55:S187-S193.
27. Keith E.R., Podmore R.G., Anderson T.P., Murdoch D.R. Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples. J Clin Microbiol 2006, 44:923-927.
28. Bernard K. The genus corynebacterium and other medically relevant coryneform-like bacteria. J Clin Microbiol 2012, 50:3152-3158.
29. Blasi F., Damato S., Cosentini R., Tarsia P., Raccanelli R., Centanni S., et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 2002, 57:672-676.
30. Post J.C., Aul J.J., White G.J., Wadowsky R.M., Zavoral T., Tabari R., et al. PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. Am J Otolaryngol 1996, 17:106-111.